Company intelligence / Profile preview

YourBio Health

Medford, Massachusetts, United Statesyourbiohealth.com ↗

Ownership: Private
Employees: ~22
Development stage: Commercial

Overview

The TAP platform is FDA-cleared and CE-marked for capillary whole blood collection. It enables virtually painless, one-step blood draws using microneedles. The technology has been validated in clinical settings including remote COVID antibody testing during the pandemic. The company continues to expand applications into decentralized diagnostics and consumer wellness.

Therapeutic areas: Hematology
Modalities: Device (specifically blood collection device)
Industry: Consumable Medical Devices

Partnerships

Miraca Holdings Inc. – strategic investment and distribution agreement announced July 2019Newpath Partners – major investor

Beyond the preview

Go deeper on YourBio Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YourBio Health.

Explore the full profile